Back to search

Article

Lipids, lipid-modifying drug Target genes and Bladder cancer: a Mendelian randomization study

2023-11-07

Abstract excerpt

<h4>Background: </h4> Bladder cancer (BLCA) is among the 10th most common malignancies with high morbidity and mortality. Statins and emerging lipid-modifying drug targets may also show potential in treating BLCA and lowering cholesterol levels. Mendelian randomization (MR) analysis provides insights into the causal relationship between exposure and disease. This study aimed to explore genetically predicted lipid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ae1a80f6-04a1-5077-ba09-d0aa1955f657
DOI
10.21203/rs.3.rs-3541205/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lipids, lipid-modifying drug Target genes and Bladder cancer: a Mendelian randomization studyDOI 10.21203/rs.3.rs-3541205/v1
Select a neighboring publication to make it the new centre.